Skip to main content
Top

Diabetologia

Issue 2/2005

Content (28 Articles)

Commentary

The hyperbolic law—a 25-year perspective

M. Stumvoll, P. A. Tataranni, C. Bogardus

Article

Relationship between HbA1c and mortality in a Japanese population

S. Nakanishi, M. Yamada, N. Hattori, G. Suzuki

Article

Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer

B. Liljeström, K. Aktan-Collan, B. Isomaa, L. Sarelin, A. Uutela, L. Groop, H. Kääriäinen, T. Tuomi

Article

Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes

Y. H. Hamid, C. S. Rose, S. A. Urhammer, C. Glümer, R. Nolsøe, O. P. Kristiansen, T. Mandrup-Poulsen, K. Borch-Johnsen, T. Jorgensen, T. Hansen, O. Pedersen

Article

mt-Nd2 Allele of the ALR/Lt mouse confers resistance against both chemically induced and autoimmune diabetes

C. E. Mathews, E. H. Leiter, O. Spirina, Y. Bykhovskaya, A. M. Gusdon, S. Ringquist, N. Fischel-Ghodsian

Article

A functional CD40 receptor is expressed in pancreatic beta cells

D. Klein, F. Barbé-Tuana, A. Pugliese, H. Ichii, D. Garza, M. Gonzalez, R. D. Molano, C. Ricordi, R. L. Pastori

Article

Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients

M. Anello, R. Lupi, D. Spampinato, S. Piro, M. Masini, U. Boggi, S. Del Prato, A. M. Rabuazzo, F. Purrello, P. Marchetti

Short communication

High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes

A. Imagawa, T. Hanafusa, H. Makino, J.-I. Miyagawa, P. Juto

Article

Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus

A. Imagawa, T. Hanafusa, Y. Uchigata, A. Kanatsuka, E. Kawasaki, T. Kobayashi, A. Shimada, I. Shimizu, T. Maruyama, H. Makino

Article

Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study

M. B. Snijder, M. Visser, J. M. Dekker, B. H. Goodpaster, T. B. Harris, S. B. Kritchevsky, N. De Rekeneire, A. M. Kanaya, A. B. Newman, F. A. Tylavsky, J. C. Seidell

Article

The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes

S. M. Pöykkö, O. Ukkola, H. Kauma, E. Kellokoski, S. Hörkkö, Y. A. Kesäniemi

Article

Dexamethasone impairs muscle energetics, studied by 31P NMR, in rats

J.-F. Dumas, G. Bielicki, J.-P. Renou, D. Roussel, P.-H. Ducluzeau, Y. Malthièry, G. Simard, P. Ritz

Article

Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes

T. Sasaoka, K. Fukui, T. Wada, S. Murakami, J. Kawahara, H. Ishihara, M. Funaki, T. Asano, M. Kobayashi

Article

Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA1c

J. A. McClung, N. Naseer, M. Saleem, G. P. Rossi, M. B. Weiss, N. G. Abraham, A. Kappas

Article

Glutamate uptake in retinal glial cells during diabetes

M. M. Ward, A. I. Jobling, M. Kalloniatis, E. L. Fletcher

Article

Determinants of subclinical diabetic heart disease

Z. Y. Fang, R. Schull-Meade, M. Downey, J. Prins, T. H. Marwick

Letters

To the Editor

T. D. R. Hockaday

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.